Transplantation Studies

Long-term Outcomes

Long-term results of tacrolimus in orthotopic liver transplant.

Drug Kinetics

Kinetics of IV and PO Mycophenolate Mofetil in living donor and deceased donor liver transplantation with tacrolimus.

Drug Interactions

Drug interactions, immunosuppressants with other drugs.

Post-Transplant Complications

Cancer Research

De novo cancers after liver transplant

PTLD Studies

Post-transplant lymphoproliferative disorder.

Rituximab Research

Role of Rituximab for post transplant lymphoproliferative disorder.

Pregnancy Outcomes

Pregnancy after transplantation.

Renal Complications

End stage renal failure after liver transplant.

Hepatitis C Research

Ribavirin Studies

Ribavirin dose concentration profile in relation to renal dysfunction in post liver transplant HCV positive patients.

Treatment Strategies

Investigational in treatment strategy with Hepatitis C viral infection in liver transplant patients.

Genotype Analysis

Outcome after liver transplant for Hepatitis C viral genotype subtypes.

Ribavirin Phosphorylation

Phosphorylation of Ribavirin.

Innovative Treatments

Immunological Research

In-vivo and In-vitro immunological markers of immunosuppression, and dose adjustment based on immunological index and equivalence of various drugs.

Drug Development

Development of a Tacrolimus analog with no nephrotoxicity.

Bioequivalence Studies

Study of bioequivalence of different forms of Valganciclovir in post transplant patients.

Specialized Studies

Pulmonary Research

Pulmonary function after liver transplant in patients with alpha 1 anti-trypsin deficiency.

Histological Studies

Role of immunohistochemical markers to distinguish recurrent hepatitis C viral infection and acute rejection in post-transplant patients.

Novel HCV Treatments

Study and development of newer drugs for Hepatitis C viral infection, protease inhibitors and other drugs, and its use to prevent HCV infection in liver transplant grafts.